Monday, March 31, 2014

Reuters: Health News: FDA allows Curis to resume testing cancer drug

FDA allows Curis to resume testing cancer drug

(Reuters) - Curis Inc said the U.S. Food and Drug Administration allowed it to resume testing its experimental cancer drug, lifting a November order h...

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/gE0RB30N5As/story01.htm


No comments:

Post a Comment

Subscribe Now: Feed Icon